Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter — ultra-fast Hanzi study All 1,152 characters from the aioLingua manual Abstract • About • The 20 audio files ← aioLingua Chinese Online ← Chinese aioLingua PDF

Influenza

Free Subscription 17.11.2025 1 Arch Virol 2 Drug Saf 1 Drugs 1 J Clin Microbiol 1 J Gen Virol 1 J Infect 2 J Infect Dis 2 J Virol 1 J Virol Methods 1 Lancet 1 PLoS Comput Biol 15 PLoS One 1 Proc Natl Acad Sci U S A 6 Vaccine 1 Virology

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Arch Virol

1. WANG P, Fu J, Wu H, Zhu L, et al
   Amino acid substitutions associated with adaptation of novel H10N3 and H10N5 avian influenza viruses to mice.
   Arch Virol. 2025;170:242.
   PubMed        
   
   

   
   Drug Saf

2. WONG J, Donegan K, Harrison K, Jan T, et al
   Implementation and Results of Active Vaccine Safety Monitoring During the COVID-19 Pandemic in the UK: A Regulatory Perspective.
   Drug Saf. 2025;48:1365-1385.
   PubMed         Abstract available
   
   
3. VAN HOLLE L
   Observed Versus Expected Analysis-How Does It Fit in the Pharmacovigilance Toolkit?
   Drug Saf. 2025;48:1325-1330.
   PubMed         Abstract available
   
   

   
   Drugs

4. LEE A
   Onradivir: First Approval.
   Drugs. 2025;85:1609-1612.
   PubMed         Abstract available
   
   

   
   J Clin Microbiol

5. HOGAN CA, Le AT, Khan A, Su LD, et al
   Comprehensive metabolomics combined with machine learning for the identification of SARS-CoV-2 and other viruses directly from upper respiratory samples.
   J Clin Microbiol. 2025;63:e0204224.
   PubMed         Abstract available
   
   

   
   J Gen Virol

6. GIOVANETTI M, Cella E, Soliani L, Prosperi A, et al
   From North to South: transmission dynamics of H1N1pdm09 swine influenza A viruses in Italy.
   J Gen Virol. 2025;106.
   PubMed         Abstract available
   
   

   
   J Infect

7. CRAWFORD-JONES D, Charlett M, Downs L, Jeffery K, et al
   Real-world utility of antigen-based testing (LumiraDX) for SARS-CoV-2 and influenza A/B in an acute hospital emergency care setting: a useful triage tool.
   J Infect. 2025;91:106649.
   PubMed        
   
   

   
   J Infect Dis

8. BUCHAN SA, Alessandrini J, Drover SSM, Andrew MK, et al
   Incidence of Respiratory Syncytial Virus-Associated Hospitalization Among Adults in Ontario, Canada, 2017-2019.
   J Infect Dis. 2025;232:e799-e810.
   PubMed         Abstract available
   
   
9. DESCHENES NM, Perez-Vargas J, Zhong Z, Thomas M, et al
   Functional and structural characterization of treatment-emergent nirmatrelvir resistance mutations at low frequencies in the main protease (Mpro) reveals a unique evolutionary route for SARS-CoV-2 to gain resistance.
   J Infect Dis. 2025 Jun 3:jiaf294. doi: 10.1093.
   PubMed         Abstract available
   
   

   
   J Virol

10. NAITO T, Ushirogawa H, Kunishio M, Yano H, et al
    Live-attenuated influenza virus vaccine strain with an engineered temperature-sensitive and genetically stable viral polymerase variant.
    J Virol. 2025 Nov 13:e0139025. doi: 10.1128/jvi.01390.
    PubMed         Abstract available
    
    
11. JUNG KI, Xia C, McKenna S, He Y, et al
    Ceramide synthase 4 interferes with replication of influenza virus but is downregulated by infection.
    J Virol. 2025 Nov 11:e0156325. doi: 10.1128/jvi.01563.
    PubMed         Abstract available
    
    

    
    J Virol Methods

12. KOPETZKY J, Mansour SC, Floyd R, Byrne L, et al
    Development and Evaluation of a Molecular Assay for the Detection and Quantification of SARS-CoV-2, influenza A, influenza B, and Respiratory Syncytial Virus from Municipal Wastewater in British Columbia.
    J Virol Methods. 2025 Nov 5:115297. doi: 10.1016/j.jviromet.2025.115297.
    PubMed         Abstract available
    
    

    
    Lancet

13. REHM J, Assanangkornchai S, Hendershot CS, Franklin A, et al
    Alcohol use disorders.
    Lancet. 2025 Oct 9:S0140-6736(25)01496-5. doi: 10.1016/S0140-6736(25)01496.
    PubMed         Abstract available
    
    

    
    PLoS Comput Biol

14. ROY M, Clapham HE, Mishra S
    Incorporating human mobility to enhance epidemic response and estimate real-time reproduction numbers.
    PLoS Comput Biol. 2025;21:e1013642.
    PubMed         Abstract available
    
    

    
    PLoS One

15. FU K, Jackson DB, Testa A
    Adverse childhood experiences and COVID-19 vaccination uptake: Examining the intersection of sex and urban-rural residence.
    PLoS One. 2025;20:e0336390.
    PubMed         Abstract available
    
    
16. POURSHABAN M, Allahbakhshian A, Hasankhani H
    Fading connections: A phenomenological study of oncology nurses' experiences of Missed Nursing Care during an infectious disease outbreak.
    PLoS One. 2025;20:e0336174.
    PubMed         Abstract available
    
    
17. BASU S
    On the mechanics of inhaled bronchial transmission of pathogenic microdroplets generated from the upper respiratory tract, with implications for downwind infection onset.
    PLoS One. 2025;20:e0335962.
    PubMed         Abstract available
    
    
18. BERKE A, Calacci D, Pentland A, Larson K, et al
    Evaluating Amazon effects and the limited impact of COVID-19 with purchases crowdsourced from US consumers.
    PLoS One. 2025;20:e0336571.
    PubMed         Abstract available
    
    
19. LEE HK, Choi JY, Park JH, Chang MH, et al
    SARS-CoV-2 spike protein causes synaptic dysfunction and p-tau and alpha-synuclein aggregation leading cognitive impairment: The protective role of metformin.
    PLoS One. 2025;20:e0336015.
    PubMed         Abstract available
    
    
20. MOORE TR, Chusan YAC, Sanderson E, Calancie L, et al
    Community-led change: Progress toward policy, systems, and environmental impacts through the Catalyzing Communities initiative.
    PLoS One. 2025;20:e0336482.
    PubMed         Abstract available
    
    
21. BONTEMPS AP, Pridgen BE, Wagner WP, Cropsey KL, et al
    A national study of substance use: Demonstrated use of recommendations for best practice online data collection.
    PLoS One. 2025;20:e0336612.
    PubMed         Abstract available
    
    
22. PANDA R, Mukherjee R, Singh K, Lahoti S, et al
    Effects of the ECHO tele-mentoring program on Long COVID management in health facilities in India: A mixed-methods evaluation.
    PLoS One. 2025;20:e0331293.
    PubMed         Abstract available
    
    
23. OYEGUN EI, Ategbole M, Jorgensen C, Fisher A, et al
    Factors associated with knowledge, attitudes, and behaviors regarding antiviral medications for COVID-19 among US adults.
    PLoS One. 2025;20:e0335182.
    PubMed         Abstract available
    
    
24. NIKAEIN K, Kanannejad Z, Ghatee MA
    Geographical and climatic risk factors for COVID-19 in southwest Iran during the 2020-2021 epidemic.
    PLoS One. 2025;20:e0336595.
    PubMed         Abstract available
    
    
25. KUMAR L, Ahmed I, Kumari C, Nasir N, et al
    Factors associated with prolonged viral shedding in COVID-19 infection: A retrospective cohort from Karachi, Pakistan.
    PLoS One. 2025;20:e0336774.
    PubMed         Abstract available
    
    
26. CORNWELL B, Ji S, Henderson SG, Meredith G, et al
    Amplification of the power of network hubs and degree skewness over infectious disease spread during lulls.
    PLoS One. 2025;20:e0322687.
    PubMed         Abstract available
    
    
27. LU M, Bu Z, Xiang N, Yu J, et al
    Association between COVID-19 vaccination and atopic diseases in US adults: A retrospective cohort study.
    PLoS One. 2025;20:e0336698.
    PubMed         Abstract available
    
    
28. SHARMIN E, Khan AI, Ahmed SF
    Clinical assessment of transplacental transfer of maternal SARS-CoV-2 IgG antibodies against spike and nucleocapsid proteins: A chemiluminescence microparticle immunoassay study.
    PLoS One. 2025;20:e0336516.
    PubMed         Abstract available
    
    
29. PHOMMASONE K, Souksakhone C, Chanthongthip A, Phonemixay O, et al
    Nationwide seroprevalence of SARS-CoV-2 during the COVID-19 pandemic and prepandemic periods in Lao PDR.
    PLoS One. 2025;20:e0336239.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

30. BI K, Bandekar SR, Bouchnita A, Cramer A, et al
    Estimated impact of 2022-2023 influenza vaccines on annual hospital burden in the United States.
    Proc Natl Acad Sci U S A. 2025;122:e2505175122.
    PubMed         Abstract available
    
    

    
    Vaccine

31. REEKIE J, Stepien S, Hendry A, Dalton L, et al
    Provider setting for influenza and COVID-19 vaccination among Australian adults in 2023 and 2024.
    Vaccine. 2025;68:127945.
    PubMed         Abstract available
    
    
32. CHENG C, Chen X, Ge Y, Sung MH, et al
    Assessing factors associated with one-year antibody waning in participants with repeated influenza vaccinations: A six-year cohort study.
    Vaccine. 2025;68:127904.
    PubMed         Abstract available
    
    
33. ZHU Y, Si M, Wang L, Zhang Y, et al
    Tolerability, safety, and preliminary immunogenicity assessment of different dosages of Quadrivalent inactivated influenza vaccine in healthy subjects aged 6-35 months: A single-center, dose-escalation, open-label phase I clinical trial.
    Vaccine. 2025;68:127962.
    PubMed         Abstract available
    
    
34. JEFFERY C, Cheyne CP, Buchan I, Garcia-Finana M, et al
    Effect of influenza vaccination on post-admission outcomes for influenza patients in England: a population-based cohort study.
    Vaccine. 2025;68:127933.
    PubMed         Abstract available
    
    
35. DENG L, Fan X, Li J, Yin D, et al
    Characteristics of neuraminidase-specific immune responses in influenza vaccinated or naturally infected populations in Shenzhen, China.
    Vaccine. 2025;69:127918.
    PubMed         Abstract available
    
    
36. DO THT, Kent SJ, Whealtey AK, Koutsakos M, et al
    Impact of serum versus anticoagulant-containing plasma on influenza virus neuraminidase-based serological assays.
    Vaccine. 2025;69:127956.
    PubMed         Abstract available
    
    

    
    Virology

37. SEEKINGS AH, Billington E, Mahmood S, Thomas SS, et al
    Infection of point-of-lay hens to assess the sequential events during H7N7 high-pathogenicity avian influenza emergence at a layer premises.
    Virology. 2025;614:110733.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Influenza is free of charge.